{
    "nctId": "NCT04495985",
    "briefTitle": "CASE 1320: RAI Uptake and Serum Prolactin in Thyroid Cancer",
    "officialTitle": "Breast Uptake on Radioiodine Scan and Serum Prolactin in Thyroid Cancer Patients Prepared by Thyroid Hormone Withdrawal or Recombinant Human Thyrotropin: A Prospective Study",
    "overallStatus": "ACTIVE_NOT_RECRUITING",
    "conditions": "Thyroid Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 39,
    "primaryOutcomeMeasure": "Breast uptake of I-131 on whole body radioactive iodine scan",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Female patients with diagnosis of differentiated thyroid carcinoma who have had thyroidectomy performed previously\n* Patients able to understand and sign informed consent for imaging\n* Patients already scheduled to undergo radioactive iodine whole body scanning (RAI WBS)\n\nExclusion Criteria:\n\n* Males\n* Patients with a history of breast cancer\n* Patients with a known history of hyperprolactinemia\n* Patients receiving medications known to raise serum prolactin",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}